| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5122(02)00002-6 |
| P698 | PubMed publication ID | 12020979 |
| P2093 | author name string | Michel Dauzat | |
| Pierre Mares | |||
| Yves Abramovici | |||
| P2860 | cites work | Hormonal Therapy Increases Arterial Compliance in Postmenopausal Women | Q63479559 |
| Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women | Q70494198 | ||
| Endothelial Control of Arterial Distensibility Is Impaired in Chronic Heart Failure | Q71807619 | ||
| Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women | Q71871472 | ||
| Pulse wave velocity measurement by cross-correlation of Doppler velocity signals. Application to elderly volunteers during training | Q71918527 | ||
| Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women | Q72852768 | ||
| Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics | Q73757319 | ||
| The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women | Q73914741 | ||
| Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function | Q74505515 | ||
| Modulation of coronary vascular resistance in female rabbits by estrogen and progesterone | Q77070723 | ||
| Smooth muscle relaxation: effects on arterial compliance, distensibility, elastic modulus, and pulse wave velocity | Q77156105 | ||
| Progesterone regulates proliferation of endothelial cells | Q77801041 | ||
| Progesterone modulates estradiol actions: acute effects at physiological concentrations | Q78228774 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
| The differential effects of oestrogens and progestins on vascular tone | Q33705980 | ||
| Cardiovascular pharmacology of hormone replacement therapy | Q33742238 | ||
| Cardioprotective effects of ovarian hormones and the HERS in perspective | Q33984342 | ||
| Chronic and acute effects of oestrogens on vascular contractility | Q34073207 | ||
| Aortic and large artery stiffness: current methodology and clinical correlations | Q37928122 | ||
| Calculation of pulse-wave velocity using cross correlation--effects of reflexes in the arterial tree | Q39252928 | ||
| The menopause and the cardiovascular system | Q39462339 | ||
| Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection | Q40825813 | ||
| Various actions of oestrogens on the vascular system | Q40835203 | ||
| Oestrogen and progesterone inhibit the stimulated production of endothelin-1. | Q42989836 | ||
| Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis | Q44706286 | ||
| Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size | Q47275963 | ||
| Effects of estrogen and progestin on aortic size and compliance in postmenopausal women | Q47330840 | ||
| Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production | Q47919752 | ||
| Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study | Q49067513 | ||
| Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. | Q50895856 | ||
| Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. | Q50931838 | ||
| Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial | Q56483516 | ||
| Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease | Q57751651 | ||
| Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women | Q58029948 | ||
| Oestrogens Attenuate Abnormal Coronary Vasoreactivity in Postmenopausal Women | Q58167003 | ||
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| estradiol valerate | Q5401768 | ||
| vasodilation | Q14859627 | ||
| Hormone Replacement Therapy | Q108667313 | ||
| P304 | page(s) | 45-53 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Maturitas | Q15766577 |
| P1476 | title | Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance | |
| P478 | volume | 42 |
| Q34766797 | Effect of Aerodiol administration on ocular arteries in postmenopausal women |
| Q46556322 | Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women |
| Q44205399 | Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women |
| Q45929033 | Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. |
| Q34918018 | Selective estrogen receptor modulators: tissue actions and potential for CNS protection. |
Search more.